<div id="readability-page-1">Virax Biolabs Group Ltd ( VRAX ) shares declined 12.79% to $0.60 in after-hours trading on Wednesday. Check out the current price of VRAX stock here. According to Benzinga Pro data, the stock closed on Wednesday at $0.69, up 75.11%. <h2>$5 Million Private Placement Details</h2> The London-based biotechnology company announced definitive agreements to sell 12.5 million ordinary shares at $0.40 per share in a private placement. H.C. Wainwright &amp; Co. is serving as the exclusive placement agent. Gross proceeds are expected to total $5 million before fees and expenses. See Also: Why Did KALA BIO Shares Jump Over 22% After Hours? <h2>Warrant Terms And Modifications</h2> The offering includes preferred investment options priced at $0.40 per share, exercisable immediately for five years. The company will also reduce the exercise prices on its 2023 Series A and Series B preferred investment options to $0.40 to match the new offering and extend their expiration to five years from the Initial Registration Statement's effective date. <h2>Expected Closing And Use Of Proceeds</h2> The transaction is expected to close on or about Thursday, subject to customary conditions. Virax intends to use net proceeds for working capital and general corporate purposes. The securities have not been registered under the Securities Act of 1933 and are being sold in a transaction not involving a public offering. <h2>Stock Performance</h2> VRAX is down 68.87% so far this year. Virax Biolabs ( VRAX ) has a market capitalization of $3.01 million and a 52-week range of $0.35 to $3.20. Benzinga Edge Stock Rankings indicate that VRAX stock has a negative price trend across all time frames. Look at other players in this segment. &lt;figure class=&#34;wp-block-image aligncenter size-full&#34;&gt;<img width="429" height="270" src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/04021011/image-61.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/04021011/image-61.png"/>&lt;/figure&gt; Read Next: <ul> <li>What Sparked Polyrizon’s (PLRZ) 140% After-Hours Stock Surge?</li> </ul> Photo Courtesy: PeopleImages on Shutterstock.com Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.</div>

VRAX

Virax Biolabs (VRAX) 的股价在盘后下跌了 12.79%，至 0.60 美元，此前股价上涨了 75.11%，达到 0.69 美元。该公司宣布进行 500 万美元的私募配售，出售 1250 万股，每股价格为 0.40 美元，H.C. Wainwright & Co. 担任配售代理。此次发行包括优先投资选项和降低的 A 类和 B 类期权行使价格。所得款项将用于营运资金和公司用途。VRAX 的股票今年下跌了 68.87%，市值为 301 万美元

Virax Biolabs (VRAX) 的股票在盘后交易中降温，此前曾上涨 75%